UT Southwestern Medical Center is a leading transplant center and has received numerous awards as well as recognition for its excellence in research, education and patient care.
Through state-of-the-art facilities and highly experienced personnel, the UT Southwestern transplant programs have established an exceptional track record. For example:
- The heart transplant program has a one-year survival rate of 91.3 percent and a three-year survivial rate of 89.7 percent, which is 10 percent higher than the national average.*
- The lung transplant program has achieved a 100 percent survival rate compared to an average of 83.6 percent for all other centers in the nation for one-year post-transplant survival of double lung transplant patients.*
- The bone marrow transplant program is actively investigating a new method of transplantation that de-emphasizes the toxic effects of high-dose chemotherapy and radiation therapy while emphasizing the powerful anti-cancer effects of donor immune cells. This treatment has resulted in complete and ongoing remissions in many patients with otherwise incurable malignancies.
- The kidney-pancreas transplant physicians are responsible for a number of innovations that have become nationally accepted practice.
- The liver transplant program provides comprehensive medical and surgical care for patients with end-stage liver disease requiring liver transplantation. The world-renowned team of surgeons and specialists can manage all aspects of the liver transplant process and provides a multidisciplinary approach to patient care.
UT Southwestern's specialists also provide the ongoing medical management and care needed for patients who are waiting for a transplant as well as for those who have already received a transplant.
The collaborative efforts of physicians, nursing coordinators, social workers and other counselors enables UT Southwestern's transplant programs to provide excellent care to every patient.
*For transplants performed between Jul. 1, 2003 and Dec. 31, 2005 for one-year data. For transplants performed between Jul. 1, 2001 and Dec. 31, 2003 for three-year data according to ustransplant.org.
